Prevention, screening, assessing and managing of non-adherent behaviour in people with rheumatic and musculoskeletal diseases: systematic reviews informing the 2020 EULAR points to consider

SUMMARY ANSWER: After formal interim analysis and premature ending of the trial, no significant difference between uterine bathing using a pharmacologically neutral sonography

I t is important for family physicians to understand the role of rheumatoid factor (RF) in manage- ment of patients with rheumatoid arthritis (RA).. Rheumatoid factors are

1 Recommendations for the assessment and optimization of adherence to disease- modifying drugs in chronic inflammatory rheumatic diseases: a process based on

Objective: To investigate how compliance during the first year of methotrexate (MTX) treatment in rheumatoid arthritis (RA) is influenced by the patients' perception of the

bDMARDs, biological DMARDs; boDMARDs, biological originator DMARDs; bsDMARD, biosimilar DMARDs; csDMARDs, conventional synthetic DMARDs; DMARDs, disease- modifying antirheumatic

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase

including: ethics, data sources, data storage, data analyses, artificial intelligence 37.. (e.g., computational modelling, machine learning), the need for

Introduction The aim of this study was to determine a low disease activity threshold - a 28-joint disease activity score (DAS28) value - for the decision to maintain